These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8928097)

  • 1. Inhibition of blood coagulation activation and oral anticoagulants in patients with mechanical heart valve prostheses.
    Barcellona D; Mameli G; Marongiu F
    Thromb Res; 1996 Feb; 81(3):403-6. PubMed ID: 8928097
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of the blood coagulation mechanism and platelet aggregation in individuals with mechanical or biological heart prostheses.
    Ferreira CN; Vieira LM; Dusse LM; Reis CV; Amaral CF; Esteves WA; Fenelon LM; Carvalho MG
    Blood Coagul Fibrinolysis; 2002 Mar; 13(2):129-34. PubMed ID: 11914655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Documentation of hypocoagulability by measurement of prothrombin fragment F 1 + 2 when introducing oral anticoagulant therapy.
    Bruhn HD; Liebsch J; Wagner C
    Thromb Res; 1992 Nov; 68(3):317-9. PubMed ID: 1471078
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous and oral sulodexide versus coagulation activation markers in humans.
    Borawski J; Dubowski M; Rydzewska-Rosolowska A; Mysliwiec M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):596-8. PubMed ID: 19910295
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
    van Wersch JW; de Vries-Hanje JC; Oosterbos C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
    Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
    Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report of a paroxysmal nocturnal hemoglobinuria with increased coagulation activation markers while on treatment with LMWH with anti-Xa levels above the therapeutic range.
    Arkel YS; Ku DH; Lake C; Lam X; Spielvogel A
    Thromb Haemost; 2000 Feb; 83(2):348-9. PubMed ID: 10739398
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct oral anticoagulant (DOAC) reversal: Andexxa versus 4 factor prothrombin concentrates.
    Tran MH; Knight B; Duong AH
    Transfus Apher Sci; 2020 Apr; 59(2):102649. PubMed ID: 31606337
    [No Abstract]   [Full Text] [Related]  

  • 10. Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model.
    Lester PA; Coleman DM; Diaz JA; Jackson TO; Hawley AE; Mathues AR; Grant BT; Knabb RM; Ramacciotti E; Frost CE; Song Y; Wakefield TW; Myers DD
    Arterioscler Thromb Vasc Biol; 2017 May; 37(5):942-948. PubMed ID: 28232327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for new oral anticoagulants with LA-resistant Russells viper venom reagents. An in vitro study.
    Exner T; Ellwood L; Rubie J; Barancewicz A
    Thromb Haemost; 2013 Apr; 109(4):762-5. PubMed ID: 23364321
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
    Becker RC; Alexander JH; Newby LK; Yang H; Barrett Y; Mohan P; Wang J; Harrington RA; Wallentin LC
    Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
    Siegal DM; Curnutte JT; Connolly SJ; Lu G; Conley PB; Wiens BL; Mathur VS; Castillo J; Bronson MD; Leeds JM; Mar FA; Gold A; Crowther MA
    N Engl J Med; 2015 Dec; 373(25):2413-24. PubMed ID: 26559317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
    Maegdefessel L; Linde T; Krapiec F; Hamilton K; Steinseifer U; van Ryn J; Raaz U; Buerke M; Werdan K; Schlitt A
    Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tick spit shines a light on the initiation of coagulation.
    Aleman MM; Wolberg AS
    Circulation; 2013 Jul; 128(3):203-5. PubMed ID: 23817576
    [No Abstract]   [Full Text] [Related]  

  • 17. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
    Turpie AG
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue factor pathway inhibitor enhances the binding of factor Xa to human monocytes.
    Li A; Chang AC; Peer GT; Wun TC; Taylor FB
    Thromb Haemost; 2001 May; 85(5):830-6. PubMed ID: 11372676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.